Brief: Scribe Therapeutics Announces Pricing Of Upsized Initial Public Offering
24/07/2026 02:10
BRIEF-Scribe Therapeutics Announces Pricing Of Upsized Initial Public Offering July 23 (Reuters) - Scribe Therapeutics Inc SCTX.O:
SCRIBE THERAPEUTICS ANNOUNCES PRICING OF UPSIZED INITIAL PUBLIC OFFERING
SCRIBE THERAPEUTICS - PRICES UPSIZED IPO OF 8,580,000 SHARES AT $15 PER SHARE
Source text: ID:nGNXXj0K8
Further company coverage: SCTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Scribe Therapeutics
See all newsBrief: Scribe Therapeutics Reports Second Quarter 2026 Financial Results And Recent Corporate Highlights
Scribe Therapeutics surges in New York debut after upsized $128.7 million IPO
U.S. STOCKS ON THE MOVE-Tenet, SLB, Digital Realty
U.S. STOCKS ON THE MOVE-Booz Allen Hamilton, Sensient, Amkor
NASDAQ RESUMED AT 11:50 AM